Skip to main content
. 2021 Nov 22;14(11):1198. doi: 10.3390/ph14111198

Figure 4.

Figure 4

Forest plots to compare lipid profile changes between ephedrine-containing products and placebo in obese or overweight patients. (A) High-density lipoprotein cholesterol (mg/dL); (B) low-density lipoprotein cholesterol (mg/dL); (C) triglycerides (mg/dL); (D) total cholesterol (mg/dL).